Archford Capital Strategies’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
HI
FCM
Archford Capital Strategies's CELG Position: Q3 2019 in Review
Archford Capital Strategies sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 347 shares — an estimated $32K sold.
Archford Capital Strategies first reported a position in CELG in Q1 2014 and held it in 18 quarters. The position peaked at $247K in Q4 2016. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.
- Archford Capital Strategies reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
- Archford Capital Strategies sold 347 Celgene Corp shares in Q3 2019, an estimated $32K.
- Archford Capital Strategies first reported a position in Celgene Corp in Q1 2014 and held it in 18 quarters.
- Archford Capital Strategies's Celgene Corp position peaked at $247K in Q4 2016.
- 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.
Based on Archford Capital Strategies's 13F filing for Q3 2019, filed 23 Oct 2019.